Cardio Diagnostics Holdings, Inc. Convertible Notes Payable
Cardio Diagnostics Holdings, Inc. (CDIO) had Convertible Notes Payable of $967.18 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleNotesPayable · last filed 2023-11-13
- 2023-09-30: Convertible Notes Payable $967.18K.
- 2023-06-30: Convertible Notes Payable $915.20K.
- 2023-03-31: Convertible Notes Payable $315.07K.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-09-30 | $967.18K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $915.20K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $315.07K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |